Bahreini S.,Shahshahani H.J.,Nasizadeh S.,Ahmadinejad M. .2021 .The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 days storage period in the hospital blood bank refrigerator. Transfus. Med, 31 : 494-498.
Cadé M.,Muñoz-Garcia J.,Babuty A.,Fouassier M.,Heymann M.F.,Monahan P.E.,Heymann D. .2021 .FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis. Drug Discov. Today, 07 : 102-116.
He Z. .2022 .Application of blood component transfusion in patients with massive blood transfusion. Chin. J. Mod. Drug Appl., 16 : 164-166.
Kobsar A.,Pfeifroth A.,Klingler P.,Niklaus M.,Schubert J.,Kuhn S.,Koessler A.,Boeck M.,Koessler J. .2022 .Composition of plasma in apheresis-derived platelet concentrates under cold storage. PMID: 35969131, : 22.
Li J.,Chen Q.,X. Q. .2014 .Research on the clinical efects of cryoprecipitate in treating infection and bleeding patients. Chin. J. Nosocomiol., 19 : 4835-4829.
Lokhandwala P.M.,Young P.P.,White J.,Brown B.L. .2022 .Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards. Transfusion, 62 : 1731-1735.
May J.E.,Wolberg A.S.,Lim A.S. .2021 .Disorders of fibrinogen and fibrinolysis. Hematol. Oncol. Clin. N. Am., 07 : 1197-1217.
Napodano C.,Gulli F.,Rapaccini G.L.,Marino M.,Basile U. .2020 .Identification, classification, and novel biomarkers of mysterious proteins. Adv. Clin. Chem, 09 : 299-340.
Obaid O.,Anand T.,Nelson A.,Reina R.,Ditillo M.,Stewart C.,Douglas M.,Friese R.,Gries L.,Joseph B. .2022 .Fibrinogen supplementation for the trauma patient: Should you choose fibrinogen concentrate over cryoprecipitate. J. Trauma Acute Care Surg., 93 : 453-460.
Piedras J.,Sánchez-Montero P.E.,Herrera F.M.,Córdova M.S.,Sánchez-Medal L. .1993 .Efect of plasma freezing temperature, anticoagulant and time of storage on factor VIII: C activity in cryoprecipitate. Arch. Med. Res., 24 : 23-26.
Politou M.,Kontoteza I.V.,Pouliakis A.,Dryllis G.,Fortsa P.,Valsami S.,Stamoulis K. .2022 .Efect of prolonged storage on quality characteristics of recovered plasma: Is there an expiration date. Transfusion, 62 : 2188-2193.
Rapaille A.,Lotens A.,Valensart N.D.,Najdovski T.,Green L. .2021 .Evaluation of the hemostatic capacity of methylene blue-treated liquid (not frozen) plasma stored up 14 days at 2° to 6°C. , 61 : 2450-2457.
Raycraft T.,Bartoszko J.,Karkouti K.,Callum J.,Lin Y. .2022 .Practice patterns of ABO-matching for cryoprecipitate and patient outcomes after ABOcompatible versus incompatible cryoprecipitate. Vox, 117 : 1105-1111.
Rühl H.,Friemann A.M.,Reda S.,Schwarz N.,Winterhagen F.I.,Berens C.,Müller J.,Oldenburg J.,Pötzsch B. .2022 .Activated factor XI is increased in plasma in response to surgical trauma but not to recombinant activated FVII-induced thrombin formation. J. Atheroscler. Thromb., 29 : 82-98.
Song Y.B. .2019 .Release of new version of technical operating procedures for blood stations. China Med, 10 : 7.
Spivey M.A.,Jeter E.K.,Lazarchick J.,Kizer J.,Spivey L.B. .1992 .Postfiltration factor VIII and ifbrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C. , 32492263448 : 2995-343.
Stahl K.,Schmidt J.J.,Seeliger B.,Schmidt B.M.W.,Welte T.,Haller H.,Hoeper M.M.,Budde U.,Bode C.,David S. .2020 .Efect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit. Care, 24 : 71.
Thomas K.A.,Shea S.M.,Spinella P.C. .2021 .Efects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro. Transfusion, 61 : 1943-1954.
Thomson C.,Sobieraj-Teague M.,Scott D.,Duncan E.,Abraham S.,Roxby D. .2021 .Extending the post-thaw viability of cryoprecipitate. Transfusion, 61 : 1578-1585.
Wang Z.,Du X.,Li C.,Ma L.,Sun P.,Cao H.,Lin F.,Ye S.,Xiao X. .2014 .Coagulation factors and inhibitors in thawed plasma stored at 1-6°C for 5 days in China. , 01 : 274-280.
Wei Z.,Dong G.,Wang F.,Xiao Y.,Fu H.,Yang C. .2023 .Analysis of factors afecting coagulation factors in fresh frozen plasma. Chin. J. Hlth. Lab, 30 : 2000-2002.
Yang J.C.,Li F.Q.,Li M.H.,Ren J.K. .2006 .Biological activities of the coagulation factor VIII, IX in platelet concentrates collected by platelet apheresis during preservation. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 14 : 162-164.
Zhou J. .2012 .Enforce and investigation of whole blood and component blood quality requirements (GB18469-. J. clin. Hematol. (Blood Trans Lab Med), 26 : 572-573.
Zhu L.,Li C.,Wang D. .2019 .Individual diferences of plasma proteins and factors in fresh frozen plasma from Chinese regional blood donors. J. Thromb. Thrombolysis, 47 : 420-426.